Dr. Sheryene Tejeda is a transformative force in the biopharmaceutical industry, renowned for her groundbreaking work in the development of OTC biologics. As the founder and CEO of Medicinal Technologies, Dr. Tejeda has not only led the company’s evolution from a biomedical research firm to a global leader in OTC biologics but has also been instrumental in shaping the future of biopharmaceuticals through innovative leadership and scientific contributions. Her business vision, combined with her scientific expertise, has made a significant impact on both the healthcare industry and the broader biopharmaceutical sector. Through her leadership, Medicinal Technologies has grown into a recognized name globally, offering accessible, affordable biologic treatments that are revolutionizing patient care.
In addition to her leadership in biopharmaceuticals, Dr. Tejeda founded the Tejeda Foundation (tejedafoundation.com/), a non-profit organization focused on advancing education, research, and healthcare in underserved communities. The foundation amplifies Dr. Tejeda’s mission of improving healthcare access and equity worldwide.
Leadership and Business Vision: Dr. Tejeda’s Role in Medicinal Technologies’ Evolution
When Dr. Sheryene Tejeda founded Medicinal Technologies, the company initially focused on biomedical research with the goal of developing treatments based on cutting-edge scientific discoveries. However, as Dr. Tejeda analyzed the evolving healthcare landscape, she saw a significant opportunity to shift the company’s focus to something more impactful: OTC biologics. This shift was a bold, visionary decision that would come to define Medicinal Technologies as a leader in the biopharmaceutical field.
